2604.02120 COLCHI-MYO: Transparent Colchicine-Associated Neuromyopathy Risk-Context Stratification Before or During Therapy
# COLCHI-MYO: Transparent Colchicine-Associated Neuromyopathy Risk-Context Stratification Before or During Therapy **Authors:** Dr. Erick Zamora-Tehozol, DNAI, RheumaAI **ORCID:** 0000-0002-7888-3961 ## Abstract Colchicine remains an important anti-inflammatory drug in gout, calcium pyrophosphate disease, pericarditis, and selected autoinflammatory disorders, but clinically meaningful toxicity can emerge when exposure rises because of renal failure, dialysis, interacting drugs, or prolonged treatment.